Evotec SE (EVO) Total Non-Current Liabilities (2009 - 2026)
Evotec SE's (EVO) quarterly Total Non-Current Liabilities came in at $30.5 million in Q2 2026, up 41.95% year-over-year from $21.5 million in Q2 2025, and down 59.42% quarter-over-quarter from $75.1 million in Q1 2026.
Analysis
Evotec SE (EVO) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $30.5 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 41.95% year-over-year to $30.5 million; the TTM figure through Jun 2026 stood at $30.5 million (up 41.95% YoY), while the FY2025 annual figure was $20.4 million, down 3.88% from the prior year.
- Total Non-Current Liabilities came in at $30.5 million for Q2 2026 at Evotec SE, down from $75.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $75.1 million in Q1 2026 to a low of $404414.5 in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $23.6 million, with a median of $20.9 million recorded in 2024.
- Year-over-year, Total Non-Current Liabilities tumbled 32.85% in 2022 and jumped 4380.75% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $16.8 million in 2022, then gained by 3.12% to $17.3 million in 2023, then rose by 21.09% to $20.9 million in 2024, then climbed by 0.31% to $21.0 million in 2025, then soared by 45.22% to $30.5 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $30.5 million in Q2 2026, $75.1 million in Q1 2026, and $21.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 22.94 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.56 Bn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 4.24 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 6.94 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 2.15 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 30.49 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 553.39 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 22.91 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.49 Mn |
| Mar 31, 2026 | 75.13 Mn |
| Dec 31, 2025 | 20.99 Mn |
| Sep 30, 2025 | 21.33 Mn |
| Jun 30, 2025 | 21.48 Mn |
| Mar 31, 2025 | 20.78 Mn |
| Dec 31, 2024 | 20.93 Mn |
| Sep 30, 2024 | 29.73 Mn |
| Dec 31, 2023 | 17.28 Mn |
| Jun 30, 2023 | 18.12 Mn |
| Dec 31, 2022 | 16.76 Mn |
| Sep 30, 2022 | 17.89 Mn |
| Jun 30, 2022 | 404,414.48 |
| Mar 31, 2022 | 19.37 Mn |
| Dec 31, 2021 | 20.62 Mn |
| Sep 30, 2021 | 26.64 Mn |
| Dec 31, 2020 | 24.72 Mn |
| Sep 30, 2010 | 9.09 Mn |
| Jun 30, 2010 | 1.12 Mn |
| Mar 31, 2010 | 1.14 Mn |